Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Epstein-Barr virus proteins.

× No keyword cloud information.

26 in total

1. Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation.

Authors: Martin Dufva; Josefine Flodin; Annika Nerstedt; Ulla Rüetschi; Lars Rymo
Journal: Nucleic Acids Res Date: 2002-05-15 Impact factor: 16.971

2. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.

Authors: J I Cohen; F Wang; J Mannick; E Kieff
Journal: Proc Natl Acad Sci U S A Date: 1989-12 Impact factor: 11.205

3. Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6.

Authors: E Altiok; J Minarovits; L F Hu; B Contreras-Brodin; G Klein; I Ernberg
Journal: Proc Natl Acad Sci U S A Date: 1992-02-01 Impact factor: 11.205

4. Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells.

Authors: P R Smith; B E Griffin
Journal: J Virol Date: 1992-02 Impact factor: 5.103

5. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.

Authors: J Finke; M Rowe; B Kallin; I Ernberg; A Rosén; J Dillner; G Klein
Journal: J Virol Date: 1987-12 Impact factor: 5.103

6. Epstein-Barr virus nuclear antigen 1 linear epitopes that are reactive with immunoglobulin A (IgA) or IgG in sera from nasopharyngeal carcinoma patients or from healthy donors.

Authors: H M Cheng; Y T Foong; C K Sam; U Prasad; J Dillner
Journal: J Clin Microbiol Date: 1991-10 Impact factor: 5.948

7. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.

Authors: J I Cohen; F Wang; E Kieff
Journal: J Virol Date: 1991-05 Impact factor: 5.103

8. The N-terminal half of EBNA2, except for seven prolines, is not essential for primary B-lymphocyte growth transformation.

Authors: R Yalamanchili; S Harada; E Kieff
Journal: J Virol Date: 1996-04 Impact factor: 5.103

Review 9. Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.

Authors: R J O'Reilly; T N Small; E Papadopoulos; K Lucas; J Lacerda; L Koulova
Journal: Springer Semin Immunopathol Date: 1998

10. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.

Authors: R Longnecker; E Kieff
Journal: J Virol Date: 1990-05 Impact factor: 5.103